Skip to content

Bariatric Surgery on the West Coast of Norway (Vestlandet)

Bariatric Surgery on the West Coast of Norway (Vestlandet): Prospective Study of Overweight People Undergoing Bariatric Surgery

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01533142
Acronym
FatWest
Enrollment
543
Registered
2012-02-15
Start date
2012-02-01
Completion date
2020-02-01
Last updated
2026-06-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus, Urinary Incontinence, Weight Loss

Keywords

lipids

Brief summary

Bariatric surgery of morbid obesity was first located at Førde Central Hospital, but it is now an established treatment at several other hospitals in the health region (Voss Hospital (Helse Bergen), Haugesund Hospital (Helse Fonna) Stavanger University Hospital ((SUS) Helse Stavanger). Surgical methods vary between hospitals: Voss: sleeve gastrectomy, Haugesund: gastric bypass (Roux-en Y),SUS: gastric bypass (Roux-en Y); Førde: biliopancreatic diversion with duodenal switch (BPD / DS) and sleeve gastrectomy . The investigators have then in Helse-Vest a unique opportunity to examine the various clinical and metabolic effects from different surgical methods. This project is part of the regional strategic research initiative in the Helse Vest

Detailed description

Primary endpoints for the study are weight loss and self-reported quality of life (QoL) evaluated by Short Form (SF)-36 and Impact of Weight Wed Quality of Life-Lite (IWQOL-Lite)) Our hypothesis is that patients operated with RYGBP (Roux A-Y Gastric Bypass) and BPD / DS (biliopancreatic diversion with duodenal switch) have the same weight and same QoL after 5 years of follow-up as patients treated with gastric sleeve (laparoscopic gastric sleeve (LSG)) We will also compare the groups with respect to a number of secondary endpoints 400 patients (approximately 100 patients / institution) will be included in the main study. Some of the programs that run on secondary endpoints will be conducted separately under study at each hospital. These studies will be reported in separate articles.

Interventions

PROCEDUREBariatric surgery

Patients will be treated with one of two bariatric procedure:: sleeve gastrectomy or gastric bypass

Sponsors

Helse Fonna
Lead SponsorOTHER
Helse Forde
CollaboratorOTHER
Helse-Bergen HF
CollaboratorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Both sexes 18-60 years old * Patients with morbid obesity that is applied to the bariatric surgery. * Signed informed consent

Exclusion criteria

* Patients who become pregnant in the follow-up period will not continue in the study but the data will be treated as lost too follow up.

Design outcomes

Primary

MeasureTime frame
weight lossFrom 1 year and up to 5 years

Secondary

MeasureTime frame
remission of diabetes mellitus type 2from 1 year up to 5 years

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 3, 2026